Company Search:
Advanced Search
Sponsored Links
Theragen Etex Co Limited Company Snapshot
Theragen Etex Co Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Theragen Etex Co Limited with three other companies in this sector in South Korea: Daehwa Pharmaceutical Company Limited (2018 sales of 110.14 billion Korean Won [US$92.85 million] of which 73% was Medicine Mafufacture), Reyon Pharmaceutical Co Ltd (122.99 billion Korean Won [US$103.68 million] of which 100% was Medicament), and Dae Han New Pharm Co., Ltd. (119.53 billion Korean Won [US$100.76 million] of which 85% was Finished Goods).

Sales Analysis. During the year ended December of 2018, sales at Theragen Etex Co Limited were 117.47 billion Korean Won (US$99.03 million). This is an increase of 9.2% versus 2017, when the company's sales were 107.59 billion Korean Won. This was the third consecutive year of growth at Theragen Etex Co Limited. Sales of Pharmaceutical Business Segment saw an increase of 16.4% in 2018, from 82.43 billion Korean Won to 95.95 billion Korean Won. Not all segments of Theragen Etex Co Limited experienced an increase in sales in 2018: sales of Healthcare and Genome Analysis Business fell 14.5% to 21.52 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Theragen Etex Co Limited
  Stock Performance Chart for Theragen Etex Co Limited
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 9,160.00
(Figures in Korean Won)
1 Week 7.4%   13 Weeks 8.0%  
4 Weeks 31.0%   52 Weeks -21.4%  
Theragen Etex Co Limited Key Data:
  Ticker: 066700 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 117,474,508,191
(Year Ending Jan 2019).
Employees: 252
  Currency: Korean Won Market Cap: 279,160,956,920
  Fiscal Yr Ends: December Shares Outstanding: 30,476,087
  Share Type: Common Closely Held Shares: 5,432,375
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.